ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TELO Telomir Pharmaceuticals Inc

5.44
0.90 (19.82%)
21 Dec 2024 - Closed
Delayed by 15 minutes

Telomir Pharmaceuticals Financial Summary

The current TELO market cap is 161.08M. The company's latest EPS is USD -0.4415 and P/E is -11.76.

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -1.08M-1.92M-1.47M-5.95M
Net Income -9.33M-6.26M-1.45M-5.93M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -138k-854k-3.94M
Net Income -138k-854k-13.07M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Assets 4.77M3.5M2.1M1.04M
Total Liabilities 1.34M486k534k600k
Total Equity 3.44M3.02M1.57M442k
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 049k4.77M
Total Liabilities 138k986k1.34M
Total Equity -138k-937k3.44M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Operating -3.86M-1.94M-3.46M-4.46M
Investing N/A N/A N/A N/A
Financing 3.86M5.21M5.35M5.3M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Operating -119k-469k-3.86M
Investing N/A N/A N/A
Financing 119k470k3.86M
Market Cap 161.08M
Price to Earnings Ratio -11.76
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 44.7
Dividend Yield -

Share Statistics

Shares Outstanding 29.61M
Average Volume (1 week) 283.38k
Average Volume (1 Month) 261.64k
52 Week Change -22.29%
52 Week High 20.72
52 Week Low 3.11
Spread (Intraday) 3.27 (42.08%)

Company Info

Company Name Telomir Pharmaceuticals Inc
Address 900 west platt street, suite 200
tampa, florida 33606
Website https://www.telomirpharma.com
Industry pharmaceutical preparations (2834)